| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.65B | 2.43B | 2.34B | 2.17B | 1.94B | 1.83B |
| Gross Profit | 777.10M | 2.23B | 536.60M | 1.27B | 1.17B | 1.10B |
| EBITDA | 1.30B | 1.16B | 886.70M | 1.03B | 997.40M | 891.50M |
| Net Income | 315.40M | 229.40M | 140.20M | 132.20M | -87.20M | 212.20M |
Balance Sheet | ||||||
| Total Assets | 17.25B | 15.91B | 14.20B | 12.24B | 11.59B | 11.09B |
| Cash, Cash Equivalents and Short-Term Investments | 1.45B | 1.02B | 953.20M | 34.20M | 115.40M | 56.20M |
| Total Debt | 10.86B | 9.70B | 8.27B | 7.30B | 6.73B | 6.62B |
| Total Liabilities | 15.44B | 14.14B | 12.37B | 11.27B | 10.33B | 9.95B |
| Stockholders Equity | 1.81B | 1.77B | 1.83B | 970.60M | 1.26B | 1.14B |
Cash Flow | ||||||
| Free Cash Flow | -814.40M | -680.50M | -356.40M | -190.20M | 62.90M | 60.00M |
| Operating Cash Flow | 869.20M | 912.30M | 813.30M | 549.50M | 709.50M | 696.60M |
| Investing Cash Flow | -1.70B | -1.54B | -1.19B | -721.70M | -650.10M | -634.90M |
| Financing Cash Flow | 1.24B | 718.60M | 1.30B | 93.20M | 4.30M | -66.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £66.23B | 21.31 | 7.66% | 4.15% | -9.52% | 35.74% | |
74 Outperform | £32.62B | 16.49 | 7.09% | 2.98% | 1.78% | -50.72% | |
72 Outperform | £9.31B | 8.14 | 20.12% | 4.45% | 15.76% | 254.82% | |
71 Outperform | £9.61B | 8.54 | 17.64% | 4.50% | 10.68% | 35.18% | |
67 Neutral | £2.63B | 9.64 | 3.09% | 6.56% | 19.50% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
59 Neutral | £9.66B | -112.68 | 1.68% | 2.86% | -4.82% | -123.58% |